It may also protect against cardiovascular outcomes in patients with type 2 diabetes and established cardiovascular disease
It's intended for people who have obesity (a body mass index, or BMI, of 30 or higher) and those with overweight (a BMI of 27 or greater) with at least one weight-related condition, such as diabetes, hypertension, or high cholesterol
InjectCos program includes continued access to clinical support, progress monitoring, and dose adjustments as needed throughout your enrollment
Tirzepatide (e.g., Mounjaro) Mechanism: Tirzepatide is a dual agonist that targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide), offering a two-pronged approach to appetite suppression and insulin regulation
If you want to take berberine, its best to consult with a healthcare provider